{
  "id": 217606,
  "title": "STAT+: Biotech’s next big bet: A Tenax study of a heart failure treatment",
  "url": "https://urgent.news/2026/08/06/stat-biotechs-next-big-bet-a-tenax-study-of-a-heart-failure-treatment",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-06T10:30:00.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/08/06/tenax-study-heart-failure-preview/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Tenax Therapeutics will soon report results from a Phase 3 study that is one of the biggest binary biotech stock events remaining in the sector this year.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}